Zihai Li
Founding Director, Pelotonia Institute for Immuno-Oncology · Ohio State University Hospital
Credentials: · · · · ·
History
PresentPelotonia Institute for Immuno-Oncology Center · Ohio State University Hospital
Hematology and Medical Oncology
Fred Hutchinson Cancer Research Center and University of Washington
Internal Medicine
Research
Combination strategies to maximize the benefits of cancer immunotherapy
Review · Journal of Hematology & Oncology · 2021 · 519 citations
Heat shock proteins transfer peptides during antigen processing and CTL priming
Review · Immunogenetics · 1994 · Last of 4 authors · 477 citations
The Journal of Experimental Medicine · 1997 · 415 citations
23 papers
- FH
16 papers
- SR
16 papers · 6 as a resident
- KH
13 papers
11 papers
9 papers · 5 as a resident
- DL
8 papers
8 papers
Grants
- 2024–2029
Targeting GARP-TGFbeta for Immunotherapy of Non-Small Cell Lung Cancer
National Cancer Institute · R01
Contact PI · $3.1M · Ohio State University
- 2023–2028
Sex, Chromosomes, and Immunity in Bladder Cancer
National Cancer Institute · P01
Project lead · $2.2M · Cedars-Sinai Medical Center
- 2021–2027
Overcoming Hypoxic Resistance in Non-Small Cell Lung Cancer By Targeting Mitochondrial Metabolism
National Cancer Institute · R01
PI · $3.6M · Ohio State University
- 2021–2027
Targeting GRP94-TGF-Beta Pathway for Cancer Immunotherapy
National Cancer Institute · R01
Contact PI · $2.9M · Ohio State University
Clinical trials
- 2000–2002
Vaccination Against High Risk Breast Cancer Using Tumor Derived Heat Shock Protein 70
Principal investigator · Terminated · Phase 1, Phase 2
UConn Health
- 2000–2002
Study Using Vaccination With Heat Shock Protein 70 (HSP70) for the Treatment of CML in Chronic Phase
Principal investigator · Completed · Phase 1
University of Connecticut
- 2001–2004
Vaccine Therapy in Treating Patients With Chronic Myelogenous Leukemia
Study chair · Completed · Phase 1
UConn Health